Abstract
Tissue repair at wound sites begins with clot formation, and subsequently platelet degranulation with the release of platelet growth factors, which are necessary and well-regulated processes to achieve wound healing. Plateletderived growth factors are biologically active substances that enhance tissue repair mechanisms, such as chemotaxis, cell proliferation, angiogenesis, extracellular matrix deposition, and remodeling. This review describes the biological background and results on the topical use of autologous platelet-rich plasma and platelet gel in gynecologic, cardiac, and general surgical procedures, including chronic wound management and soft-tissue injuries.
Keywords: Platelets, platelet-rich plasma (PRP), platelet gel (PG), growth factors, wound healing, cardiac surgery, gynecology, general surgery, adipose graft.
Current Pharmaceutical Biotechnology
Title:Is the Use of Autologous Platelet-Rich Plasma Gels in Gynecologic, Cardiac, and General, Reconstructive Surgery Beneficial?
Volume: 13 Issue: 7
Author(s): Peter A.M. Everts, Maarten M. Hoogbergen, Tjaarda A.Weber, Roger J.J. Devilee, Gust van Monftort and Ignace H.J.T. de Hingh
Affiliation:
Keywords: Platelets, platelet-rich plasma (PRP), platelet gel (PG), growth factors, wound healing, cardiac surgery, gynecology, general surgery, adipose graft.
Abstract: Tissue repair at wound sites begins with clot formation, and subsequently platelet degranulation with the release of platelet growth factors, which are necessary and well-regulated processes to achieve wound healing. Plateletderived growth factors are biologically active substances that enhance tissue repair mechanisms, such as chemotaxis, cell proliferation, angiogenesis, extracellular matrix deposition, and remodeling. This review describes the biological background and results on the topical use of autologous platelet-rich plasma and platelet gel in gynecologic, cardiac, and general surgical procedures, including chronic wound management and soft-tissue injuries.
Export Options
About this article
Cite this article as:
A.M. Everts Peter, M. Hoogbergen Maarten, A.Weber Tjaarda, J.J. Devilee Roger, van Monftort Gust and H.J.T. de Hingh Ignace, Is the Use of Autologous Platelet-Rich Plasma Gels in Gynecologic, Cardiac, and General, Reconstructive Surgery Beneficial?, Current Pharmaceutical Biotechnology 2012; 13 (7) . https://dx.doi.org/10.2174/138920112800624346
DOI https://dx.doi.org/10.2174/138920112800624346 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Improved Anti-inflammatory Activity and Potential Cytoprotective Properties of Tolfenamic Acid, Naproxen and Indomethacin Derivatives
Letters in Drug Design & Discovery Biologic Therapy and Treatment Options in Diabetic Retinopathy with Diabetic Macular Edema
Current Drug Safety Inflammatory Cells and Proteases in Abdominal Aortic Aneurysm and its Complications
Current Drug Targets 3D Printing in Medical Applications
Current Medical Imaging The Association of Connective Tissue Disorders with Cervical Artery Dissections
Current Molecular Medicine Antiplatelet Treatment in Stroke: New Insights
Current Pharmaceutical Design Genetic and Molecular Determinants of Atherosclerotic Plaque Instability
Current Vascular Pharmacology The Epidemiology and Health Effects of Tobacco Use
Current Pediatric Reviews Contribution and Value of Biomarkers in Acute Aortic Syndromes
Current Pharmaceutical Biotechnology Homocysteine and Non-Cardiac Vascular Disease
Current Pharmaceutical Design Testosterone Deficiency in Male: A Risk Factor for Heart Failure
Endocrine, Metabolic & Immune Disorders - Drug Targets Visceral and Subcutaneous Adiposity: Are Both Potential Therapeutic Targets for Tackling the Metabolic Syndrome?
Current Pharmaceutical Design LncRNAs as Architects in Cancer Biomarkers with Interface of Epitranscriptomics- Incipient Targets in Cancer Therapy
Current Cancer Drug Targets Application of Current Diagnostic Criteria for Arrhythmogenic Right Ventricular Cardiomyopathy in Every Day Clinical Practice
Current Pharmaceutical Design Diverse Functions and Mechanisms of Pericytes in Ischemic Stroke
Current Neuropharmacology Protein Kinases and their Modulation in the Central Nervous System
Current Medicinal Chemistry - Central Nervous System Agents Role, Function and Therapeutic Potential of microRNAs in Vascular Aging
Current Vascular Pharmacology Intravenous Immunoglobulin Therapy in Dermatologic Disorders
Inflammation & Allergy - Drug Targets (Discontinued) Adrenergic and V1-ergic Agonists/Antagonists Affecting Recovery from Brain Trauma in the Lund Project Act on Astrocytes
Current Signal Transduction Therapy Renal and Cardiac Effects of Renal Sympathetic Denervation and Carotid Baroreceptor Stimulation
Current Vascular Pharmacology